The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Cerner Corp

Nasdaq: CERN
Last

(U.S.) $71.23

Today's change+0.33 +0.47%
Updated August 4 10:30 AM EDT. Delayed by at least 15 minutes.
 

Cerner Corp

Nasdaq: CERN
Last

(U.S.) $71.23

Today's change+0.33 +0.47%
Updated August 4 10:30 AM EDT. Delayed by at least 15 minutes.

Cerner Corp up (U.S.)$0.33

Cerner Corp is up today by (U.S.)$0.33 or 0.47% to (U.S.)$71.23. Over the last five days, shares have gained 4.00% and 10.16% year to date. Shares have outperformed the S&P 500 by 20.80% during the last year.

Key company metrics

  • Open(U.S.) $70.65
  • Previous close(U.S.) $70.90
  • High(U.S.) $71.27
  • Low(U.S.) $70.48
  • Bid / Ask(U.S.) $71.21 / (U.S.) $71.28
  • YTD % change+10.16%
  • Volume184,490
  • Average volume (10-day)2,484,514
  • Average volume (1-month)1,947,839
  • Average volume (3-month)2,073,558
  • 52-week range(U.S.) $53.65 to (U.S.) $75.72
  • Beta0.50
  • Trailing P/E48.26×
  • P/E 1 year forward33.47×
  • Forward PEG1.86×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.48
Updated August 4 10:30 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+14.30%

Based on its net profit margin of 14.30%, Cerner Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 04, 201504/04/2015Jan 03, 201501/03/2015Sep 27, 201409/27/2014Jun 28, 201406/28/2014
Revenue996926840852
Total other revenue--------
Total revenue996926840852
Gross profit827753700689
Total cost of revenue169173140162
Total operating expense829721652660
Selling / general / administrative533441415400
Research & development98797272
Depreciation / amortization29282525
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income167205188192
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax167208190194
Income after tax111148129129
Income tax, total56616165
Net income111148129129
Total adjustments to net income--------
Net income before extra. items111148129129
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items111148129129
Inc. avail. to common incl. extra. items111148129129
Diluted net income111148129129
Dilution adjustment--------
Diluted weighted average shares352350349350
Diluted EPS excluding extraordinary itemsvalue per share0.320.420.370.37
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.320.420.370.37